Medtronic plc Stock
€70.74
Your prediction
Medtronic plc Stock
Pros and Cons of Medtronic plc in the next few years
Pros
Cons
Performance of Medtronic plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medtronic plc | -0.530% | -1.995% | -6.453% | -4.509% | -13.774% | -14.668% | -34.226% |
| Dexcom Inc. | -0.380% | -4.727% | -2.675% | -16.918% | -8.583% | -53.239% | -39.943% |
| Teleflex Inc. | -1.200% | 3.036% | 15.400% | -1.368% | 13.137% | -52.314% | -67.765% |
| Baxter International | 0.610% | -1.220% | 13.945% | -40.643% | -3.051% | -62.792% | -78.147% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.
Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.
Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.
Comments
News
3 Healthcare Stocks That Pay You While You Wait for the Growth
Some dividend payers suspend their dividend programs when they encounter headwinds, such as slower growth. Others double down and continue issuing regular payouts while they work out ways to
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
Some investors have watched their healthcare stock holdings drop in value recently or over the years, yet they have stuck around. That's because those companies are still paying dividends with
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations
Boston Scientific (NYSE:BSX), a medical device developer, closed Wednesday at $64.87, up 8.99%. The stock is jumping after a Q1 earnings beat paired with lowered 2026 guidance. Investors are